Gareth Davies

Title: Gareth Davies - Innovator in Antibody Research

Introduction

Gareth Davies is a notable inventor based in Slough, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins. His work has implications for medical research and therapeutic applications.

Latest Patents

Gareth Davies holds a patent for the Gremlin-1 antibody. This invention relates to crystals of the human Gremlin-1 protein and its complex with an inhibitory antibody. The patent also covers the structure of human Gremlin-1, both independently and in complex with the antibody. Furthermore, it outlines the use of these structures in screening for agents that modulate Gremlin-1 activity. The invention provides antibodies that bind to an allosteric inhibitory site on Gremlin-1, along with pharmaceutical compositions and medical uses of these antibodies and agents identified through the screening methods. He has 1 patent to his name.

Career Highlights

Gareth Davies is associated with Ucbbiopharma Srl, where he continues to advance his research in antibody development. His work is pivotal in understanding the mechanisms of Gremlin-1 and its potential therapeutic applications.

Collaborations

Gareth collaborates with esteemed colleagues, including Michael John Wright and Breda Twomey. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Gareth Davies is a prominent figure in antibody research, with a focus on the Gremlin-1 protein and its applications in medicine. His innovative work and collaborations contribute significantly to advancements in biotechnology.